The use of neutralizing antibodies to myostatin improved muscle disorders in rodent models of DMD (mdx) and limb-girdle muscular dystrophy 2f (Sgcg−/−) (Bogdanovich et al., 2002; Bradley et al., 2008). This evidence concerns the gene MSTN and limb-girdle muscular dystrophy.